secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0001640334-24-000708
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria exercises warrants for ~$4.4M, issues new warrants with $4.75 strike
----------------------------------------------------------------------------

- Existing investor exercises 2,917,032 warrants for ~$4.4M; gross proceeds ~$4.7M including new warrant consideration.
- New warrants for 2,917,032 shares at $4.75 strike, expiring Feb 2029; $0.125/share consideration paid.
- Company to file resale registration statement within 60 days for new warrant shares.
- H.C. Wainwright earns 6% tail fee on proceeds and receives 102,097 warrants at $5.9375.
- New warrants include 9.99% beneficial ownership limitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424000708/0001640334-24-000708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033424000708/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-000708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer